Patent · US Active

Vaccine

US7910117B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Isis Innovation Limited · GB

Inventors

Joyce Susan Plested · Felton, GB
Michael Paul Jennings · Forsayth, AU
Margaret Ann Jaqueline Gidney · Ottawa, CA
Andrew Cox · Ottawa, CA
James Clare Richards · Ottawa, CA
Richard Edward Moxon · Felton, GB

Key dates

Filing date	Jul 24, 2009
Grant date	Mar 22, 2011
Priority date	—
Expiry date	Jul 24, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.